169 [ ] spatial uneven events (GIS) (spatial correlations) (spatial statistics) (Croner et al., 2; Aziz et al., 212; Shafie 211) (point pattern analysis) (clustering patterns) (Maheswan and Haining, 24) (kernel estimation) (geostatistical methods) (risk surface estimation) (raster or cell-based) (Bithell, 199, 1999; Diggle, 2). (temporal kinetics) ARIMA (autoregressive integrated moving average model) (Zeger et al., 24; Earnest et al., 25) Wen et al., 26; Eisen & Lozano-Fuentes 29; Jeefoo, Tripathi, and Souris 211; Alzahrani et al., 213) - 192 197
17 1952-1965 1952 1965 1995 2 213 8 215 7 1. 192 197 (TB) (BCG) 211 196-197 BCG TB TB WHO TB BCG UICIF BCG BCG UICEF WHO TB ( ) BCG
171 Tuberculosis Male Mortality Rate, 196-1967 Tuberculosis Male Mortality Rate, 1968-1978 Mortality Rate per 1, poputation 61-96 51-6 41-5 31-4 15-3 Mortality Rate per 1, poputation 51-15 41-5 31-4 21-3 1-2 196-1967 23-27 Tuberculosis Female Mortality Rate, 196-1967 Tuberculosis Female Mortality Rate, 1968-1978 Mortality Rate per 1, poputation 51-73 41-5 31-4 21-3 8-2 Mortality Rate per 1, poputation 31-5 21-3 16-2 11-15 -14 196-1967 23-27 WHO BCG 2.
172 Meters 4,5 9, 18, 27, 36, W S E - 度 - - 流行 3 3. (Chronic Obstructive Pulmonary Disease, COPD) 3 COPD 24 3 5.1% 63.6 22 COPD 1981 33.2 27 3.9 (ICD-9 496) COPD COPD
173 3 2 1 1 2 3 Meters 4,5 9, 18, 27, 36, W S E Mortality per 1, 3 25 2 15 1 Total Male Female 5 2 22 24 26 Year 1999-27 1999 27 COPD 3 PM 1 CO COPD COPD O 2 COPD (GWR) 49.4% 72.2% 6.9% 77.9% -Local Moran s I (A) (B) GWR
174 (A) (B) ot Significant High-High Cluster High-Low Outlier Low-High Outlier Low-Low Cluster 2 4 8 ot Significant High-High Cluster High-Low Outlier Low-High Outlier Low-Low Cluster 2 4 8 (A) (B) (A) (B) PM1_MEA 82.6-93.45 72.92-82.59 61.62-72.91 48.66-61.64 22.7-48.65 2 4 8 Legend Cities/Counties Townships Altitude (meters) 1-99 1-199 2-299 3-399 4-499 5-599 6-699 7-799 8-899 9-999 1,-1,499 15,-1,999 2,-2,499 2,5-3,893 12.5 25 5 75 1 (A) 1994-1999 PM 1 (B) 4. (Chronic Kidney Disease, CKD) 3 213 211 (ESRD) 9% 213 5.89% 28-212 26
研究動態報導 175.6.55 Male.52.5 ESRD/CKD Ratio Female.51.45.41.39.41.37.4.34.31.3.2.1. 圖九 28 28 29 21 Year 211 212 28-212 年末期腎臟病病人佔全部慢性腎臟病病人的比例 29 Prevalence rate (per 1,) 21 Prevalence rate (per 1,) Prevalence rate (per 1,) 117-1387 946-116 85-945 75-84 68-74 536-67 37-412 33-36 117-1387 946-116 85-945 75-84 68-74 536-67 37-412 -36 2 4 117-1387 946-116 85-945 75-84 68-74 536-67 37-412 67-36 8 211 2 4 8 212 Prevalence rate (per 1,) 2 4 8 Prevalence rate (per 1,) 117-1387 946-116 85-945 75-84 68-74 536-67 37-412 74-36 117-1387 946-116 85-945 75-84 68-74 536-67 37-412 72-36 圖十 2 4 8 2 4 8 28-212 年慢性腎臟病鄉鎮盛行率估計 始 末期腎臟病前期(Pre-ESRD)之病人照護與衛 資料的空間資訊只有病患的投保鄉鎮與就醫醫 教計畫 及 初期慢性腎臟病醫療給付改善方案 療院所的鄉鎮 這對於推估疾病盛行率是一大挑 發揮了早期介入與積極治療的效果 降低慢性腎 戰 本研究參考以往的研究成果進行推估 慢性 臟病病人進入末期腎臟病的機會 腎臟病的盛行率地圖如圖十所列 在西半部以嘉 依據全民健康保險研究資料庫的慢性腎臟 義縣 嘉義市 台南市 高雄市交界的山區鄉鎮 病患資料進行鄉鎮盛行率的推估 由於目前健保 為盛行率較高的地區 而死亡率的趨勢則由於疾 民國 14 年 11 月 自然科學簡訊第二十七卷第四期
176 Age-adjusted mortality (per 1, population) 3 25 2 15 1 5 2 21 22 23 24 25 26 Year ICD 9 (585) to ICD 1 (18) Male Female 27 28 29 21 211 212 2-212 Local Relative Risk (Male, 28-212) Local Relative Risk (Female, 28-212) Legend Cities/Counties Relative Risk (p <.5).94-1.52 1.521-2.25 2.256-3.52 3.526-4.89 4.897-6.47 6.471-8.54 8.549-12.54 Legend Cities/Counties Relative Risk (p <.5) 1.25-1.61 1.612-2.16 2.182-3.13 3.313-4.35 4.355-5.52 5.527-7.25 7.251-1.25 12.525 5 75 1 W S E 1 3 6 8 12 W S E 28 ICD-9 ICD-1 28-212 1. BCG
177 195 BCG UICEF WHO BCG TB TB 196 UICEF BCG TB 2 TB BCG BCG 196 BCG 196 2. 利 例 - - - 3.